Anlotinib in Combination with TQB2450 in Patients with Recurrent Ovarian Cancer (ACTION): A Multicenter, Single-Arm, Open-Label, Phase Ib Trial.
JOURNAL OF CLINICAL ONCOLOGY(2021)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2021)